Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Sponsor: GlaxoSmithKline
Summary
This is a Phase 3, randomized, open-label study designed to evaluate safety and efficacy of belantamab mafodotin in combination with bortezomib/dexamethasone (Arm A) versus daratumumab in combination with bortezomib/dexamethasone (Arm B) in the participants with relapsed recurrent multiple myeloma.
Official title: DREAMM 7: A Multicenter, Open-Label, Randomized Phase III Study to Evaluate the Efficacy and Safety of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (B-Vd) Compared With the Combination of Daratumumab, Bortezomib and Dexamethasone (D-Vd) in Participants With Relapsed/Refractory Multiple Myeloma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
494
Start Date
2020-05-07
Completion Date
2028-06-30
Last Updated
2026-04-23
Healthy Volunteers
No
Conditions
Interventions
Belantamab mafodotin
Humanized anti-B-cell maturation antigen (BCMA) antibody/drug conjugate
Daratumumab
Anti-cluster of differentiation 38 \[CD-38\] monoclonal antibody
Bortezomib
Proteasome Inhibitor
Dexamethasone
Synthetic glucocorticoid with anti-tumor activity
Locations (69)
GSK Investigational Site
Yuma, Arizona, United States
GSK Investigational Site
Denver, Colorado, United States
GSK Investigational Site
Kansas City, Kansas, United States
GSK Investigational Site
Fairfield, Ohio, United States
GSK Investigational Site
Tyler, Texas, United States
GSK Investigational Site
Liverpool, New South Wales, Australia
GSK Investigational Site
Wollongong, New South Wales, Australia
GSK Investigational Site
Benowa, Queensland, Australia
GSK Investigational Site
Brussels, Belgium
GSK Investigational Site
Brussels, Belgium
GSK Investigational Site
Ghent, Belgium
GSK Investigational Site
Roeselare, Belgium
GSK Investigational Site
Beijing, China
GSK Investigational Site
Jinan, China
GSK Investigational Site
Shenyang, China
GSK Investigational Site
Alexandroupoli, Greece
GSK Investigational Site
Athens, Greece
GSK Investigational Site
Thessaloniki, Greece
GSK Investigational Site
Tel Aviv, Israel
GSK Investigational Site
Bergamo, Italy
GSK Investigational Site
Meldola FC, Italy
GSK Investigational Site
Milan, Italy
GSK Investigational Site
Siena, Italy
GSK Investigational Site
Aichi, Japan
GSK Investigational Site
Aichi, Japan
GSK Investigational Site
Aomori, Japan
GSK Investigational Site
Ehime, Japan
GSK Investigational Site
Fukuoka, Japan
GSK Investigational Site
Fukuoka, Japan
GSK Investigational Site
Fukuoka, Japan
GSK Investigational Site
Fukuoka, Japan
GSK Investigational Site
Gifu, Japan
GSK Investigational Site
Gunma, Japan
GSK Investigational Site
Hyōgo, Japan
GSK Investigational Site
Kanagawa, Japan
GSK Investigational Site
Kanagawa, Japan
GSK Investigational Site
Kochi, Japan
GSK Investigational Site
Nagano, Japan
GSK Investigational Site
Okayama, Japan
GSK Investigational Site
Osaka, Japan
GSK Investigational Site
Osaka, Japan
GSK Investigational Site
Shizuoka, Japan
GSK Investigational Site
Dordrecht, Netherlands
GSK Investigational Site
Groningen, Netherlands
GSK Investigational Site
Chorzów, Poland
GSK Investigational Site
Krakow, Poland
GSK Investigational Site
Lodz, Poland
GSK Investigational Site
Lublin, Poland
GSK Investigational Site
Lublin, Poland
GSK Investigational Site
Nowy Sącz, Poland
GSK Investigational Site
Poznan, Poland
GSK Investigational Site
Warsaw, Poland
GSK Investigational Site
Moscow, Russia
GSK Investigational Site
Nizhny Novgorod, Russia
GSK Investigational Site
Novosibirsk, Russia
GSK Investigational Site
Saint Petersburg, Russia
GSK Investigational Site
Saint Petersburg, Russia
GSK Investigational Site
Saratov, Russia
GSK Investigational Site
Ufa, Russia
GSK Investigational Site
Pusan, South Korea
GSK Investigational Site
Ulsan, South Korea
GSK Investigational Site
Barcelona, Spain
GSK Investigational Site
Barcelona, Spain
GSK Investigational Site
Cáceres, Spain
GSK Investigational Site
Gijón, Spain
GSK Investigational Site
L'Hospitalet de Llobrega, Spain
GSK Investigational Site
Murcia, Spain
GSK Investigational Site
PamplonaNavarra, Spain
GSK Investigational Site
Salamanca, Spain